A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.

Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Study results show that genetic sensitivity to stress was linked to a 49% higher risk of lung cancer in people of European ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

SHANGHAI, China I 5, 2025 I Shanghai Henlius Biotech, Inc. (2696.HK) announced that its anti-PD-1 mAb, HANSIZHUANG (serplulimab, marketed as ...

In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an ...

Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...

Bladder cancer often begins with subtle symptoms that are easy to overlook. The most common early sign is blood in the urine, a condition known as hematuria. In many cases, the blood may not always be ...

A phase 3 trial is evaluating ASP-1929 photoimmunotherapy plus Keytruda in first-line treatment for recurrent head and neck ...

A researcher with The University of Texas Health Science Center at San Antonio School of Dentistry and her biotechnology company teamed with the school to earn a $400,000 Small Business Technology ...